Allergen-specific immunoglobulin G4 against Vespula species venom allergens (Vespula sIgG4) (Vespula sIgG4)

Allergen-specific Immunoglobulin G4 (sIgG4) against Vespula species (yellow jacket) venom allergens is a specialized antibody subclass that plays a critical role in the development of immune tolerance. It is primarily induced during venom immunotherapy (VIT), where it targets major venom allergens such as Ves v 1 (phospholipase A1) and Ves v 5 (antigen 5) (Ruëff et al., 2011). The biological function of sIgG4 is to act as a "blocking antibody" by competitively binding to these allergens, thereby preventing them from cross-linking allergen-specific IgE on the surface of mast cells and basophils (Shamji & Durham, 2017). This blockade effectively inhibits the degranulation process and the subsequent release of inflammatory mediators like histamine, which are responsible for life-threatening anaphylactic reactions (Vazquez-Ortiz & Du Toit, 2016). Additionally, IgG4 can interact with the inhibitory receptor FcγRIIb to further suppress immune cell activation (Akdis & Akdis, 2014). In clinical practice, measuring levels of Vespula-specific IgG4 serves as a vital biomarker for monitoring the efficacy of immunotherapy and the successful shift from a Th2-mediated allergic response to a tolerant state (Hofmann et al., 2023).

Other names

Yellow jacket venom-specific IgG4Vespula venom-specific IgG4sIgG4 to Vespula allergensVes v-specific IgG4

Vespula venom extracts induce the production of allergen-specific IgG4, which then acts as a competitive inhibitor (blocking antibody) to prevent allergen-IgE binding and subsequent mast cell activation.